Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Times of India
The Times of India
National
Swati Bharadwaj | TNN

As demand dips, Bharat Biotech slows Covaxin output for maintenance in Hyderabad

HYDERABAD: Bharat Biotech on Friday announced the temporary slowing down of production of its Covid-19 vaccine Covaxin across its manufacturing facilities as it has completed its supply obligations. The company also said that it expected a decrease in demand for the indigenous vaccine.

The Hyderabad-based vaccine maker said that for the coming period, the company will focus on pending facility maintenance, process and facility optimisation. Sources said that the company had hit a peak of about 8 crore doses of Covaxin every month in early 2022.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.